• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>TheraSense

TheraSense

  1. Medivation Files Definitive Consent Revocation Statement and Mails Letter to Stockholders

    Medivation Files Definitive Consent Revocation Statement and Mails Letter to Stockholders

  2. Durvalumab Monotherapy Demonstrates Efficacy in Urothelial Bladder Cancer

    Durvalumab Monotherapy Demonstrates Efficacy in Urothelial Bladder Cancer

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.